Wednesday, 26 August 2026European Markets

ASR NEDERLAND Stock Bearish By 16% In The Last 5 Sessions

Loading stream...

(VIANEWS) - Shares of ASR NEDERLAND (AEX-Index: ASRNL.AS) dropped by a staggering 16.43% in 5 sessions from €43.76 to €36.57 at 16:09 EST on Wednesday, after four consecutive sessions in a row of losses. AEX-Index is falling 2.44% to €719.51, following the last session's upward trend.

ASR NEDERLAND's last close was €38.62, 16.57% below its 52-week high of €46.29.

About ASR NEDERLAND

ASR Nederland N.V. provides insurance, pensions, and mortgages products for consumers, self-employed persons, and companies. It operates through five segments: Non-Life, Life, Asset Management, Distribution and Services, and Holding and Other. The company distributes insurance contracts; provides financial intermediary services; and develops real estate properties. It operates as an asset manager for third parties. ASR Nederland N.V. offers its products under the De Amersfoortse, Loyalis, Ditzo, Europeesche Verzekeringen, and Ardanta brand names. The company was formerly known as Fortis Verzekeringen Nederland N.V. and changed its name to ASR Nederland N.V. in October 2008. ASR Nederland N.V. was founded in 1720 and is headquartered in Utrecht, the Netherlands.

Earnings Per Share

As for profitability, ASR NEDERLAND has a trailing twelve months EPS of €5.07.

PE Ratio

ASR NEDERLAND has a trailing twelve months price to earnings ratio of 7.21. Meaning, the purchaser of the share is investing €7.21 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.26%.

Volume

Today's last reported volume for ASR NEDERLAND is 774979 which is 10.25% below its average volume of 492449.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASR NEDERLAND's stock is considered to be overbought (>=80).

More news about ASR NEDERLAND (ASRNL.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com